Insmed Inc (NASDAQ: INSM) kicked off on Tuesday, down -1.40% from the previous trading day, before settling in for the closing price of $71.96. Over the past 52 weeks, INSM has traded in a range of $21.92-$80.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 275.45% over the past five years. While this was happening, its average annual earnings per share was recorded 2.14%. With a float of $167.85 million, this company’s outstanding shares have now reached $171.85 million.
Let’s look at the performance matrix of the company that is accounted for 912 employees. In terms of profitability, gross margin is 76.84%, operating margin of -203.45%, and the pretax margin is -243.37%.
Insmed Inc (INSM) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Insmed Inc is 2.33%, while institutional ownership is 105.73%. The most recent insider transaction that took place on Sep 13 ’24, was worth 2,072,223. In this transaction Chief Legal Officer of this company sold 27,871 shares at a rate of $74.35, taking the stock ownership to the 67,856 shares. Before that another transaction happened on Sep 13 ’24, when Company’s Chief Medical Officer sold 26,969 for $74.90, making the entire transaction worth $2,019,978. This insider now owns 106,134 shares in total.
Insmed Inc (INSM) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 2.14% per share during the next fiscal year.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Take a look at Insmed Inc’s (INSM) current performance indicators. Last quarter, stock had a quick ratio of 2.53. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 37.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.40, a number that is poised to hit -1.20 in the next quarter and is forecasted to reach -4.24 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Insmed Inc (NASDAQ: INSM) saw its 5-day average volume 0.95 million, a negative change from its year-to-date volume of 2.29 million. As of the previous 9 days, the stock’s Stochastic %D was 10.11%. Additionally, its Average True Range was 2.11.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 61.36%, which indicates a significant increase from 21.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.68% in the past 14 days, which was lower than the 39.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $73.61, while its 200-day Moving Average is $50.69. Nevertheless, the first resistance level for the watch stands at $71.62 in the near term. At $72.28, the stock is likely to face the second major resistance level. The third major resistance level sits at $72.98. If the price goes on to break the first support level at $70.26, it is likely to go to the next support level at $69.56. The third support level lies at $68.90 if the price breaches the second support level.
Insmed Inc (NASDAQ: INSM) Key Stats
The company with the Market Capitalisation of 12.19 billion has total of 171,849K Shares Outstanding. Its annual sales at the moment are 305,210 K in contrast with the sum of -749,570 K annual income. Company’s last quarter sales were recorded 90,340 K and last quarter income was -300,610 K.
